5 financial challenges facing the medtech sector

As medical device leaders gather this week at AdvaMed’s annual Medtech Conference, several questions loom over the industry. After years of pandemic-driven uncertainty, supply chain snags and financial pressures, what does growth look like for the sector? And how will technologies including artificial intelligence and a new class of GLP-1 drugs affect medical device companies in the long term?

The challenges that emerged last year have intensified, according to a report released Monday by professional services firm Ernst & Young. Investment and mergers have declined, as have companies’ stocks and IPOs.